MEDNATION AG (EIF.DE) Stock Fundamental Analysis
Europe - FRA:EIF - DE0005653604 - Common Stock
3.34 EUR
+0.28 (+9.15%)
Overall EIF gets a fundamental rating of 3 out of 10. We evaluated EIF against 27 industry peers in the Health Care Providers & Services industry. The financial health of EIF is average, but there are quite some concerns on its profitability. EIF does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
EIF had positive earnings in the past year.
EIF had a positive operating cash flow in the past year.
In multiple years EIF reported negative net income over the last 5 years.
EIF had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EIF has a Return On Assets of 0.29%. This is in the lower half of the industry: EIF underperforms 70.37% of its industry peers.
EIF has a worse Return On Equity (0.90%) than 74.07% of its industry peers.
EIF has a Return On Invested Capital of 2.01%. This is in the lower half of the industry: EIF underperforms 77.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EIF is below the industry average of 5.99%.
The 3 year average ROIC (1.75%) for EIF is below the current ROIC(2.01%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.29% | ||
| ROE | 0.9% | ||
| ROIC | 2.01% |
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
1.3 Margins
EIF has a worse Profit Margin (0.21%) than 74.07% of its industry peers.
With a Operating Margin value of 2.95%, EIF is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of EIF has declined.
Looking at the Gross Margin, with a value of 90.58%, EIF belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of EIF has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.95% | ||
| PM (TTM) | 0.21% | ||
| GM | 90.58% |
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EIF is destroying value.
EIF has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EIF has been reduced compared to 5 years ago.
EIF has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.89 indicates that EIF is not a great score, but indicates only limited risk for bankruptcy at the moment.
EIF has a Altman-Z score of 1.89. This is comparable to the rest of the industry: EIF outperforms 55.56% of its industry peers.
EIF has a debt to FCF ratio of 8.55. This is a slightly negative value and a sign of low solvency as EIF would need 8.55 years to pay back of all of its debts.
EIF has a Debt to FCF ratio (8.55) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.06 is on the high side and indicates that EIF has dependencies on debt financing.
EIF has a Debt to Equity ratio (1.06) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 8.55 | ||
| Altman-Z | 1.89 |
ROIC/WACC0.46
WACC4.39%
2.3 Liquidity
EIF has a Current Ratio of 1.57. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.57, EIF is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
EIF has a Quick Ratio of 1.38. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.38, EIF belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.57 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
EIF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.94%.
Looking at the last year, EIF shows a small growth in Revenue. The Revenue has grown by 7.56% in the last year.
EIF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.13% yearly.
EPS 1Y (TTM)-85.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.57%
Revenue 1Y (TTM)7.56%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%3.33%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 167.00, EIF can be considered very expensive at the moment.
Based on the Price/Earnings ratio, EIF is valued a bit more expensive than 74.07% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.08. EIF is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 167 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EIF is valued a bit cheaper than 74.07% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EIF is valued a bit cheaper than 74.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.23 | ||
| EV/EBITDA | 7.19 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
EIF does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EIF (10/24/2025, 7:00:00 PM)
3.34
+0.28 (+9.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.13%
Ins Owner ChangeN/A
Market Cap10.42M
Revenue(TTM)48.76M
Net Income(TTM)104.60K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 167 | ||
| Fwd PE | N/A | ||
| P/S | 0.21 | ||
| P/FCF | 7.23 | ||
| P/OCF | 4.51 | ||
| P/B | 0.9 | ||
| P/tB | 0.9 | ||
| EV/EBITDA | 7.19 |
EPS(TTM)0.02
EY0.6%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.46
FCFY13.84%
OCF(TTM)0.74
OCFY22.2%
SpS15.63
BVpS3.71
TBVpS3.7
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.29% | ||
| ROE | 0.9% | ||
| ROCE | 4.73% | ||
| ROIC | 2.01% | ||
| ROICexc | 2.23% | ||
| ROICexgc | 2.23% | ||
| OM | 2.95% | ||
| PM (TTM) | 0.21% | ||
| GM | 90.58% | ||
| FCFM | 2.96% |
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)1.97%
ROICexgc(5y)N/A
ROCE(3y)4.15%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y6.43%
ROICexc growth 3YN/A
ROICexc growth 5Y6.41%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
F-Score7
Asset Turnover1.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 8.55 | ||
| Debt/EBITDA | 4.48 | ||
| Cap/Depr | 66.39% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 84.1% | ||
| Profit Quality | 1378.59% | ||
| Current Ratio | 1.57 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 1.89 |
F-Score7
WACC4.39%
ROIC/WACC0.46
Cap/Depr(3y)35.94%
Cap/Depr(5y)25.78%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.56%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%3.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.59%
EBIT growth 3YN/A
EBIT growth 5Y-8.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y134.09%
FCF growth 3Y-18.54%
FCF growth 5Y-3.22%
OCF growth 1Y133.4%
OCF growth 3Y-13.99%
OCF growth 5Y-5.06%
MEDNATION AG / EIF.DE FAQ
Can you provide the ChartMill fundamental rating for MEDNATION AG?
ChartMill assigns a fundamental rating of 3 / 10 to EIF.DE.
What is the valuation status of MEDNATION AG (EIF.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to MEDNATION AG (EIF.DE). This can be considered as Overvalued.
Can you provide the profitability details for MEDNATION AG?
MEDNATION AG (EIF.DE) has a profitability rating of 3 / 10.
What is the financial health of MEDNATION AG (EIF.DE) stock?
The financial health rating of MEDNATION AG (EIF.DE) is 5 / 10.